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Abstract: Decellularized bone matrix is receiving much attention as biological scaffolds and
implantable biomaterials for bone tissue regeneration. Here, we evaluated the efficacy of a cell-free
demineralized bone matrix on mesenchymal stem cells (MSCs) survival and differentiation in vitro.
The seeding of human umbilical cord-derived MSCs (hUC-SCs) on decellularized bone matrices
up to 14 days was exploited, assessing their capability of scaffold colonization and evaluating gene
expression of bone markers. Light and Scanning Electron Microscopies were used. The obtained
cell-free decalcified structures showed elastic moduli attributable to both topology and biochemical
composition. Morphological observation evidenced an almost complete colonization of the scaffolds
after 14 days of culture. Moreover, in hUC-SCs cultured on decalcified scaffolds, without the addition
of any osteoinductive media, there was an upregulation of Collagen Type I (COL1) and osteonectin
(ON) gene expression, especially on day 14. Modifications in the expression of genes engaged in
stemness were also detected. In conclusion, the proposed decellularized bone matrix can induce the
in vitro hUC-SCs differentiation and has the potential to be tested for in in vivo tissue regeneration.
Keywords: decellularized bone matrix; MSCs; gene expression; tissue engineering
1. Introduction
To develop an efficient and bioactive scaffold with the ability to encourage, guide, and regulate
tissue renewal, it is important to consider three main connected factors: 1) the use of a highly
biocompatible and bioactive biomaterial; 2) a material easily processable to mime tissue topology; and
3) a scaffold topology fostering the mechanical characteristics of a native tissue in the initial stage of
development, as shown by Engler [1].
In recent years, several resorbable synthetic and natural polymers have been explored as
biomaterials for bone tissue engineering and regenerative medicine approaches; materials such
as poly(lactic acid), polycaprolactone, poly(glycolic acid), polyurethanes, or their blends have been
widely used [2,3]. Indeed, they show restricted (e.g., just adhesive groups) or absence of bioactive
moieties to improve the biocompatibility and this significantly bounds their regenerative capacity. This
weakness can be mainly overcome by either functionalizing the outer surface of scaffolds or just mixing
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growth factors into the bulk material, so that they can be available with the biomaterial degradation [4].
Biologically-derived proteinaceous materials, such as collagen and fibrin or glycosaminoglycans
(e.g., hyaluronic acid), have also been tested [5–8]. A current method is to arrange different substances
to produce a composite structure: Blending bioactive ceramics with polymers improves the mechanical
properties of a scaffold, reduces the ceramic brittleness, and increases both scaffolds [9]. Composite
scaffolds are consequently expected to be physically and biologically better than single-material based
ones. Moreover, the composite features may also be tuned by mixing the different compounds in
different ratios since both the composition and relative ratio of constituent materials have an impact
on tissue formation. As far as bone is concerned, Hydroxyapatite (HA) has been employed as a key
material combined with tricalcium phosphate, poly(lactic-co-glycolic acid) (PLGA), or chitin, to develop
different composite scaffolds [10]. Bone scaffolds have been also developed using composite materials
based on carbon nanotubes (CNTs) [11,12], which allow to obtain microfabricated scaffolds with
good biocompatibility coupled with excellent mechanical and electrical properties [13,14]. Moreover,
synthetic polymers, such as PLGA, were combined with bioglasses, developing scaffolds with an
elastic modulus in the range of natural bone tissue, and endowed with a good cell interaction also in
term of stem cell osteoblastic differentiation [15].
Tissue decellularization was first reported in 1973 [16] as a method to preserve tissue planned
as a protective barrier for burn patients. The biochemical composition and 3D organization of the
Extracellular Matrix (ECM) is characteristic for each tissue type and it entails the functional molecules
secreted by tissue resident cells as well as the tissue structure [17]. Since ECM is capable to dynamically
and reciprocally influence cell behavior [18], over the past several decades the mimicking of the
composition and structure of the ECM has directed the coherent design of biomaterials in attempts
to properly influence cell performances [19,20]. The increased interest to use ECM derived from the
decellularization of tissues or organs as biomaterial allowed to develop functional tissues such as skin,
bladder, heart valve and small intestinal submucosa [21].
As far as bone tissue regeneration is concerned, the “gold standard” is represented by bone graft
that, encompassing low levels of bone morphogenetic proteins (BMPs), is osteoconductive [22]. Bone
decellularization and demineralization result in a spongy deformable scaffold, maintaining osteoconductive
properties, that can be used as a bone void filler and as a matrix for cells. Therefore, the use of decellularized
bone matrix as scaffolds could furnish tissue-specific ECM cues that influences the behavior of resident
and/or seeded cells. Indeed, the actual impact of the ECM mechanics of a cell-free and demineralized
scaffold—regardless the microstructure - on the osteogenic differentiation of endogenous osteoprogenitor
cells, which arrange bone regeneration and repair, is still to be completely elucidated [23].
In a decellularization process there are still concerns on the need to remove each cell component to
avoid disease transmission, inflammation and/or immune responses towards the scaffold, and decrease
the risk of rejection after implantation. Moreover, it is mandatory to optimize reagents and time for
decellularization, to remove only cell components without affecting bio-cues promoting bone cell
activities and functions.
Based on these considerations, we have optimized the protocol of decellularization and
demineralization of bovine cancellous bone proposed by Eagle and Collagen Type I (COL1). [24] to
produce scaffolds not only endowed by chemical bone matrix cues [25] but also with the topological
features of a native bone tissue. These scaffolds were then seeded human mesenchymal stem cells
(MSCs) derived from umbilical cord (hUC-SCs) to evaluate if they provide a suitable environment for
cell adhesion and maintenance.
2. Results
2.1. Bone Demineralization and Mechanical Tests
Decalcification ended after the second day of immersion in decalcifying solution, as shown by
decalcification test where no precipitate was found. Figure 1 shows the morphological appearance, as well
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as an example of a characteristic compressive stress-strain curve, of the obtained demineralized sample.
As it is shown in the graph, it is possible to determine two elastic moduli: the one for low strains is
principally due to the topology of the demineralized bone scaffold, whilst the elastic modulus for high
strain is relative to the biochemical composition of the scaffolds. The obtained elastic moduli values were
2.91± 2.3 MPa and 23.25± 7.54 MPa, respectively. Data obtained were in line with literature [26]. Scanning
electron microscopy (SEM Philips XL 20, FEI Italia SRL, Milan, Italy) observation and Hematoxylin-Eosin
staining demonstrated a bony trabecular network with the absence of cells.
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Figure 1. Representative: (A) Demineralized scaffold; (B) stress-strain curve of demineralized bone;
(C) SEM observation with bony trabecular network and empty osteocytic lacunae (arrows).
2.2. Isolation and Characterization of Human Umbilical Cord Stem Cells (hUC-SCs)
Evaluation of hUC-SC surface markers were made by flow cytometry at the 3rd cell passage of
subculture. Cells expressed CD73, CD90, and CD105 antigens and were negative for CD34, CD45,
HLA-DR and CD14. According to the minimal criteria recommended by the International Society for
Cellular Therapy [27], our cells could be considered to be MSCs. Besides, our cell population displayed
a lower expression level of CD9 with respect to Human Dermal Fibroblasts (HDFs), with a Mean
Fluorescence Intensity (MFI) of 94.18 in hUC-SCs and 167.76 in HDFs. This data confirms that the
analyzed cell populations were homogenous with no fibroblast contamination [28] (Figure 2a). In vitro
differentiation assays demonstrated the ability of hUC-SCs to differentiate, in appropriate culture
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conditions, into chondrocytes, osteoblasts, and adipocytes (Figure 2b–d), strengthening their belonging
to the MSCs family.
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Figure 2. hUC-SC flo ic phenotypi ch racterizatio and n vitro differentiation ass ys.
(a) r t ristic single-variable histograms display negative control (black line) and th expression of
cell surface antigens (grey) on hUC-SCs and Hu an er al Fibroblasts (HDFs); (b) osteogenic
differentiation of hUC-SCs after 21 days of induction (Von Kossa staining); (c) chondrogenic
differentiation of hUC-SCs after 14 days of induction (Alcian Blue staining); (d) adipogenic differentiation
of hUC-SCs after 14 days of induction (Oil Red staining). Image magnification 20×, scale bars 50 µm.
2.3. Scaffold Colonization
SEM observation at 7 days of culture evidenced the colonization of cell-free demineralized
structures by hUC-SCs, with randomly disperse cells on the surface of the scaffolds, as well as within
the macropores. Most cells have an elongated, fibroblast-like appearance.
At 14 days, scaffolds were covered with a multilayered canopy of cells growing inwardly.
Cellular boundaries were indiscernible due to the flattened morphology and intimate contact between
neighboring cells. Blebbing on cell surface was also evident (Figure 3a–h).
Light microscopy (LM, Nikon Eclipse 600, Nikon Instruments Spa, Florence, Italy) images were
consistent with SEM observation at both time points analyzed with cells adhering the surface of the
scaffolds (Figure 3i,j).
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Figure 3. SEM micrographs of scaffolds cultured with hUC-SCs for 7 (a–c) and 14 (d–h) days at different
magnifications. Cells were able to adhere and colonize the scaffolds. Note the presence of membrane blebs
after 14 days of culture suggestive of active metabolizers. Light microscopy (LM) micrographs of cells
on demineralized scaffold at 7 (i) and 14 (j) days of culture: H = Haversian canal; green arrows indicate
osteocytic lacunae; blue arrows indicate hUC-SCs; (k) histograms depict changes in Alkaline Phosphatase
(ALP), Collagen Type 1 (COL1), ostenectin (ON; also known as secreted protein acidic and rich in cysteine
(SPARC)), osteocalcin (OC; also known as bone gamma-carboxyglutamic acid-containing protein (BGLAP),
sex-determining region Y (SRY)-Box2 (Sox2), and octamer-binding transcription factor 4 (Oct4) mRNA
expression in hUC-SCs. Data are expressed as fold-change (2−∆∆Ct) of the expression at 14 days culture
over 7 days one: square brackets indicate significant differences (p < 0.05).
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2.4. Gene Expression
Data on mRNA relative expression in the different subculture passages are summarized in Table 1.
Table 1. mRNA relative expression.
Genes 7 Days 14 Days
Mean DS Mean DS p
ALP 2.93 × 10−4 1.47 × 10−5 2.46 × 10−4 1.23 × 10−5 0.039
COL1 1.33 × 10−1 6.64 × 10−3 4.99 × 10−1 2.50 × 10−2 0.0096
SPARC 1.52 × 10−1 7.59 × 10−3 4.89 × 10−1 2.44 × 10−2 0.013
BGLAP 4.96 × 10−6 2.48 × 10−7 3.64 × 10−6 1.82 × 10−7 0.047
Oct4 9.79 × 10−4 4.89 × 10−5 5.21 × 10−4 2.60 × 10−5 0.034
Sox2 3.93 × 10−5 1.97 × 10−6 1.77 × 10−5 8.85 × 10−7 0.042
A significant increase in COL and osteonectin (ON), i.e., secreted protein acidic and rich in
cysteine (SPARC)), mRNA expression was detected after 14 days of culture in comparison with cells
cultured for only 7 days. On the contrary, a significant decrease was noticed in the expression of
Alkaline Phosphatase (ALP) and of the latest marker of osteoblastic differentiation (i.e., osteocalcin
(OC; also known as bone gamma-carboxyglutamic acid-containing protein (BGLAP) between the
two time-point analyzed. As far as gene involved in stemness is concerned (i.e., octamer-binding
transcription factor 4 (Oct4) and sex-determining region Y (SRY)-Box2 (Sox2), a significant decrease
in both genes’ mRNA expression was detected after 14 days of culture. It must be stressed that gene
expression was significantly lower of that detected in cells cultured in tissue culture plates (TCPs) (data
not shown).
These changes were also analyzed using the ∆∆Ct method [29], comparing mRNA expression of
hUC-SCs cultured for 14 days with that of cells after 7 days of culture (Figure 3k). A 3-fold increase in
COL1 and ON mRNA expression was observed in cells cultured for 14 days on the demineralized
scaffolds in comparison with those cultured for 7 days. Concomitantly, there was a reduction in the
expression of gene involved in the maintenance of self-renewal profile (Figure 3k).
3. Discussion
Biological scaffolds composed of ECM and derived from different mammalian tissue
decellularization are broadly utilized in clinical applications involving the healing and regeneration of
tissues and organs (e.g., musculoskeletal tissues, gastrointestinal or lower urinary tract) [30]. The goal
of tissue decellularization is the exhaustive elimination of cells and debris while maintaining, as much
as possible, the composition and 3D ultrastructure of the native ECM. The initial studies on tissue
decellularization removed cellular material and retained the structural and functional proteins of the
ECM, such as glycosaminoglycans (GAGs), proteoglycans, and growth factors [31]. ECM materials
harvested by such methods and appropriately processed preserved the biochemical complexity,
nanostructure, and bioinductive properties of the natural matrix, being able to encourage the in vivo
creation of site-specific, functional tissue [32]. Several ECM-derived materials are FDA-approved, can
be conserved and used ‘off the shelf,’ have been extensively characterized in both the 2D sheet and
powder forms, and have been implanted in millions of patients to date [32–34].
The ideal methods of decellularization depends on tissue-specific factors, such as cell number,
matrix density, and geometric thoughts, including tissue thickness and shape. The whole removal
of all cell fragments is not possible and, predictably, decellularization procedures can cause some
alteration in matrix architecture, orientation, and surface ligand sites. Therefore, micro-architectural
features, which include ECM fiber orientation, connectivity, intersection spatial density, and diameter
(i.e. network topology), are not always well preserved during these processes. As far as bone is
concerned, this decellularization needs to be optimized to avoid the removals of biocues supporting
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bone cell activities and coupling mechanisms between osteoclasts and osteoblasts. The produced
structures, able to encourage a tissue remodeling, must also favor the recruitment and differentiation
of stem/progenitor cells [24,35].
In this respect, the proposed decellularized scaffolds evidenced a good growth and colonization
by hUC-SCs. These cells are attractive for several tissue engineering applications, as they are derived
from an ethically undisputed source and may be non-invasively harvested at low cost [36–39]. Our
observation is in line with data of Xu et al. [40], who showed a good proliferation for hUC-SCs cultured
on medium-stiffness matrices. In their work, the authors also evidenced that on the medium-stiffness
matrices, which were comparable to pre-mineralized bone, hUC-SCs presented a spindle-shaped cells
similar in morphology to myoblasts rather than osteoblast as described in Engler’s work [41]. Even if
cell shape is not necessarily suggestive of stem cell differentiation, our scaffolds’ cells showed a spindle
shaped morphology with evident blebs, which were suggestive of an osteoblastic induction.
Gene expression results showed a reduction of mRNAs involved in self-renewal, indicating
the capability of the proposed scaffolds to start cell differentiation also in the absence of any other
microenvironmental signal. Indeed, cells showed an increase only of COL1 and ON, whilst genes
involved in mineralization seemed to be downregulated. This feature could be at least in part
attributable to the lack of appropriate differentiation cues, in addition to material stiffness, that could
induce the expression of ALP and OC. Comparable data were obtained by Witkowska-Zimny et al.’s
research, who did not show changes in the expression of ALP during UC-SCs osteogenic differentiation
on matrix scaffold [42]. In addition, differences could also exist between UC-SCs and other sources of
MSCs, such as periosteal derived stem cells, in terms of osteogenic potential [23,43].
According to the obtained results, the proposed scaffolds obtained by bovine cancellous bone
could be suitable tools for the in vitro testing of cell behavior due to the inductive effects of ECM-
derived molecules in term of adhesion, growth, and differentiation.
Our results also emphasize the importance of topography as a determinant of cellular behavior
within a porous substrate. More investigations are still required to elucidate the exact effects of this
scaffold and its interactions with MSCs.
4. Materials and Methods
4.1. Bone Demineralization and Mechanical Tests
We obtained three-dimensional (3D) bone spongy scaffolds from bovine cancellous bone, obtained
from the femur of 18-month-old bovines (2 males and 2 females) [44]. Slices of 40 mm × 15 mm and
of 2–3 mm of thickness were first washed with sodium hypochlorite and then demineralized using
2% (w/v) HCl 0.5N solution in water (Sigma, Milan, Italy) about 50 ml for gram of bone [24]. Bath
solution was changed every day and decalcification was evaluated mixing one part of bath solution
with two parts of a solution made of equal part of 5% (w/v) NH3 and 5% (w/v) Ammonium Oxalate [45].
Decalcification was stopped after 24 h if they were not precipitate. Samples were then washed in
ultrapure water and allowed to dry before performing mechanical tests.
Young’s modulus of 3D bone scaffolds (six samples) was evaluated using uniaxial testing machine
Zwick/Roell mod. Z005, equipped with a 100 N cell load (Zwick Roell Italia S.r.l., Genova, Italy).
Compression tests were performed with the following parameters: 0.1 N of preload, strain rate equal
to 1% of sample thickness, and 30% of maximum deformation.
Data were analyzed with Excel, and Young’s modulus was obtained from linear regression of
initial portion of stress-strain curve. Samples were also fixed in 10% neutral buffered formaldehyde
(Diapath S.P.A., Martinengo, Italy) for at least 2 days and processed according to standard histology
(see below).
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4.2. Isolation and Culture of Human Umbilical Cord Mesenchymal Stem Cells (hUC-SCs)
hUC-SCs were isolated from Wharton’s jelly of 5 healthy full-term pregnancies after women
informed consent obtainment. Samples were collected in agreement with the guidelines of the National
Bioethics Committee and handled following a procedure approved by the University of Bologna.
Briefly, umbilical cords were finely minced and subjected to enzymatic digestion with 0,1% (w/v)
collagenase (Gibco, Thermo Fisher, Monza, Italy) in phosphate buffer saline (PBS) for 3 h at 37 ◦C in a
humidified incubator. Digestion products were filtered by a sterile cell strainer (70 µm in diameter) to
remove ECM debris. The filtrate was then washed several times with PBS supplemented with 10%
(v/v) fetal bovine serum (FBS) (Gibco, Thermo Fisher) and, at last, cultured in Dulbecco’s modified
eagle medium/nutrient mixture F-12 (DMEM/F12) (Life Technologies, Milan, Italy) containing 10%
FBS and 1% penicillin–streptomycin (100 U/mL) in cell culture flasks to allow the adhesion of primary
hU-SCs. Culture medium was completely replaced twice a week. Cells were detached at 80–90%
confluency with 0.25% trypsin in 1mM ethylenediaminetetraacetic acid (EDTA) (Gibco, Thermo Fisher)
and split 1:2.
The staminal profile of 3rd passaged hUCs was assessed by flow cytometry considering the
minimal criteria for the identification of human MSCs [27]. To this aim 2.5 × 106 cells were aliquoted in
round-bottom polystyrene tubes, washed with PBS and then stained for 45 min at 4 ◦C with mouse
anti-human FITC (Fluorescein isothiocyanate) or PE (Phycoerythrin)-conjugated monoclonal antibodies
against the following surface antigens: HLA-DR, CD34, CD105, CD14, CD19, and CD45 (Diaclone,
Besancon, France); CD73 and CD90 (StemCell Technologies, Inc. Vancouver, BC, Canada) and CD9
(Thermo Fisher). HDFs were used to compare CD9 expression levels. Control for FITC- or PE-coupled
antibodies was an isotypic mouse IgG1. Flow cytometric analysis was performed using FACSCalibur
flow cytometry system (Becton Dickinson, CA, USA) and FCS Express 6 Plus Software (De Novo
Software, Los Angeles, CA, USA).
4.3. hUC-SC In Vitro Differentiation
At the 3rd passage, the ability of hU-SCs to differentiate into mesenchymal lineages was evaluated.
For osteogenic differentiation, hU-SCs were plated at the density of 5 × 104 cells with STEMPRO®
Osteogenesis Kit in chamber-slides (Lab-Tek II Chamber Slide, Nalgene Nunc International, Thermo
Fisher). After 21 days, Von Kossa staining was performed to assess the appearance of calcium deposits.
Briefly, cells were fixed in 4% paraformaldehyde (PFA) for 15 min at room temperature (RT) and
incubated with a 1% silver nitrate solution under UV light for 20 min at RT. Unreacted silver was
removed with 5% sodium thiosulfate solution for 5 min. To assess the differentiation into adipocytes,
4 × 104 hU-SCs were seeded in chamber-slides with STEMPRO® Adipogenesis Kit and after 15 days
Oil Red staining was performed to visualize lipid droplets. Cells fixed in 4% PFA were washed two
times with PBS and one time with isopropanol 60%. After incubation with Oil Red O solution 0.5%
(w/v) in absolute isopropanol diluted 3:2 with dH2O for 30 min at RT, cells were washed in dH2O
and counterstained with Mayer’s hematoxylin (BioOptica, Milan, Italy). For chondrogenesis, pellet
culture system was used. In brief, 1 × 106 cells in 1mL of STEMPRO® Chondrogenesis Kit were
centrifuged at 1200 rpm for 5 min. Pellets were cultured for 14 days and then fixed in 4% PFA, paraffin
embedded, and sectioned. Sections were incubated with a solution of Alcian Blue pH 1 (Bio-Optica,
Milan, Italy) for 20 min at RT and then washed with dH2O. Previous kits were all purchased from
Gibco (Thermo Fisher). All the reactions were examined with a light microscope (Nikon Eclipse 600)
equipped with a Nikon DSVi1 digital camera (Nikon Instruments) and NIS Elements BR 3.22 imaging
software (Nikon Instruments).
4.4. Scaffold Seeding and Culture
Before seeding, demineralized 3D scaffolds, placed in Corning® ultra-low attachment multiwell
plates were sterilized at each side under UV for 30 min and then incubated in 70% ethanol (Sigma-Aldrich,
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Milan, Italy) for 1 h. Scaffolds were then conditioned by rinsing in complete DMEM/F12 (supplemented
as previously described) overnight in a humified incubator (37 ◦C at 5% CO2). After media removing,
scaffolds were considered ready for cell seeding. hUC-SCs were detached from culture flasks using
0.25% trypsin in 1mM EDTA and seeded on samples at a density of 2x105 cells/sample in a volume
of 50 µL. After 1 h of incubation at 37 ◦C, scaffolds were fixed with CellCrown™ (Scaffdex, Tampere,
Finland) to prevent sample floating, and 1 ml of complete DMEM/F12 was added in each well. hUC-SCs
were further cultured on the demineralized 3D scaffolds for 7 and 14 days. Media were changed twice
a week. hUC-SCs cultured at a density of 2 × 105 cells/well on TCPs for 7 and 14 days were used as
controls for real-time quantitative reverse transcription (qRT)-PCR assays.
4.5. Scanning Electron Microscopy (SEM)
For SEM observation, cell-seeded demineralized 3D scaffolds were fixed in 2.5% glutaraldehyde
in 0.1 M cacodylate buffer, post-fixed in 1% osmium tetroxide, dehydrated in increasing ethanol
concentrations (25, 50, 70, 80, and 100%) and hexamethyldisilazane (HDMS)-dried, mounted on
aluminum stubs, gold-sputtered by the Edwards Sputter Coater B150S equipment and observed
with a Philips XL 20 SEM (FEI Italia SRL, Milan, Italy) microscope. All reagents were purchased
from Sigma-Aldrich.
4.6. Light Microscopy (LM)
For LM, cultured specimens (7 and 14 days) were fixed in 10% buffered formaldehyde (Diapath
S.P.A) embedded in paraffin (AppliChem GmbH, Darmstadt, Germany), sectioned to a thickness of
5–6 µm and stained with Hematoxylin-Eosin (Bio-Optica S.P.A., Milano, Italy) for routine histological
examination. The sections were dewaxed in xylene (Carlo Erba Reagents, Val-de-Reuil, France) and
rehydrated through a graded series of ethanol (Carlo Erba Reagents).
4.7. Real-Time Quantitative Reverse Transcription PCR (qRT-PCR)
Total RNA was retrieved from cells cultured for 7 and 14 days on decellularized bone scaffolds and
TCPs with TRIzol® Reagent (Invitrogen, Milan, Italy), according to the manufacturer’s instructions.
RNA quantification and the evaluation of its quality were made by spectrophotometric analysis
(bioPhotometer plus, Eppendorf GmbH, Hamburg, Germany): 2.5 µg of total RNA was reverse
transcribed in a 20 µL reaction volume using the SuperScript IV VILO Master Mix (Thermo Fisher).
Neo-synthesized cDNA was kept at −20 ◦C.
Mastercycler Realplex2 thermocycler (Eppendorf GmbH) was used for real-time assays with
SsoFast™ EvaGreen® Supermix 1× in a final volume of 10 µL. All PCR reactions included 1 µL of
cDNA (equivalent to 50 ng of total RNA template). Primer sequences were designed by Primer 3
(v. 0.4.0, ThermoFisher®Primers) software and each primer was used at a 200nM final concentration. To
circumvent any substantial homology to pseudo-genes or other unexpected targets, primer specificity
was tested by BLAST Assembled RefSeq Genomes. Table 2 depicts oligonucleotide sequences for
target and reference genes. mRNA of both reference genes and each gene of interest were measured
under matching conditions and at the same time in each assay. Primers exhibited equal amplification
efficiency. Specificity of the PCR reactions was also determined by melt curve analysis: For each
amplicon, the detected melting temperature was the expected one.
Threshold Cycle (Ct) values for reference genes were utilized to normalize cell mRNA data.
Each assay was made in triplicate. Normalization involved the ratio of mRNA concentrations
for specific genes of interest (as mentioned above) to that corresponding to Ct medium values for
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and beta glucuronidase (GUSB) [46]. Data
were expressed as gene relative expression (2−∆Ct). To point out the effect of scaffolds on hUC-SCs,
∆∆Ct method for Fold-Change evaluation was used comparing values obtained in cells cultured for
14 days with those seeded for only 7 days [29]. The qPCR efficiency in all our experiments was more
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than 90%. The difference between the actual and theoretical (100%) efficiencies would result in an
underestimation of the mRNA concentration of all the analyzed samples.
Table 2. Analyzed gene description.
Genes DetectedTranscript Primer Forward (5
′→3′) Primer Reverse (3′→5′) Amplicon Length(bp)
ALP NM_007431 GGCCAGCTACACCACAACA CTGAGCGTTGGTGTTATATGTCTT 96
COL1 NM_000088.3 CCAACCCTTCCACCTTTGGAAGT CCGGAGGTCCACAAAGCTGAA 132
SPARC NM_003118.3 CCTGAGGCTGTAACTGAGAGAAAG GTGGGAGGGGAAACAAGAAGATAA 142
BGLAP NM_199173 GACTGTGACGAGTTGGCTGA GCCCACAGATTCCTCTTCTG 119
Sox2 NM_003106.3 ACACCAATCCCATCCACACT GCAAACTTCCTGCAAAGCTC 198
Oct4 NM_203289.4 AGCGAACCAGTATCGAGAAC GCCTCAAAATCCTCTCGTTG 199
GUSB * NM_000181.2 AAACGATTGCAGGGTTTCAC TCTCGTCGGTGACTGTTCA 81
GAPDH * NM_002046.3 AGCCACATCGCTCAGACAC GCCCAATACGACCAAATCC 200
* Reference genes: GUSB = beta glucuronidase; GAPDH = glyceraldehyde-3-phosphate dehydrogenase.
4.8. Statistical Analysis
SAS statistical package (Statistical Analysis System Institute) was used. All experiments were
carried out in triplicate and results are expressed as mean ± Standard Deviation (SD). ANOVA and
Bonferroni tests were used to analyze the differences. Statistical significance was set at p < 0.05.
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